Latest available resultsQuarter ended March 31, 202610-Q · April 28, 2026
Filed with the SECINCYTE CORP
INCYHealthcare
Results announcedJuly 28, 2026▲ +44.1%
Detailed filing pendingNext reportOctober 26, 2026Analyst forecast -3.46 $/share
Revenue
$1.27B
▲ +20.9% vs prior year% YoY
Net income
$303.33M
▲ +91.7% vs prior year% YoY
EPS
1.47$
▲ +83.7% vs prior year% YoY
Net margin
23.8%
▲ +8.8 percentage points vs prior year pp YoY
Revenue▲ +20.9 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +91.7 %
EPS▲ +83.7 %
View financial tableQuarter ended March 31, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $1.27B | |
| Gross profit | $1.17B | 91.8 % |
| Operating income | $301.12M | 23.7 % |
| Net income | $303.33M | 23.8 % |
| R&D | $515.90M | 40.5 % |
| EPS (diluted) | 1.47 $ | |
| Balance sheet | ||
| Assets | $7.34B | |
| Liabilities | $1.72B | |
| Equity | $5.62B | |
| Cash | $3.46B | |
| Capital | ||
| Shares outstanding | 199.78M | as of 2026-04-21 |
| Public float | — | |